A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

Clinical trial NCT00322153 · COMPLETED

Trial details

NCT number: NCT00322153
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dementia of the Alzheimer's Type

Start date: 2005-06-01
Primary completion: 2007-10-01
Enrollment: 677

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.